Table 1

Data collection schedule

VariableDescriptionData sourceData collection time points
Baseline4 weeks8 weeks12 weeks
DemographicAge, genderLeecare
Medical conditionsDiagnosis of medical conditionLeecare
Medications*Name, strength, dose, frequency of medicine administrationMedi-Map
Nutritional statusSwallowing statusLeecare
Functional abilityMobilisation statusLeecare
Cognitive functionMontreal Cognitive AssessmentLeecare
Falls historyNumber of falls and related health outcomesLeecare
Vital signsHeight, weight, blood pressure (systolic and diastolic), respirations, pulse, BGL, SpO2Leecare
PainPainChek score severity across six domainsLeecare
Residential Medication Management Review (RMMR)Dates of RMMR provision will be recordedOn-site aged care pharmacist
Physical activityTime spent in light, moderate, vigorous-intensity activityFibion SENS device
SleepMovements during sleep, durations of light, deep and REM sleepFibion Emfit device
Edmonton Symptom Assessment ScaleSeverity across 10 symptomsParticipant or third-party informant review
Adverse eventsFor example, falls, fracture, delirium, faecal impaction, incontinenceLeecare, pharmacists, aged care staff, residents
IncidentsMedication incidents will be recorded including date/time and severityLeecare, pharmacists, aged care staff, residents
Ambulance call-outsDate and reasons will be recordedLeecare, pharmacists, aged care staff, residents
Hospital visitsDate and reason of emergency department visits or hospital admission will be recordedLeecare, pharmacists, aged care staff, residents
All-cause mortalityAny deaths in the 12-week study period will be recordedAged care staff
  • *Data will be collected and exported daily into the TCC-ADEPT platform over the 12-week study period.

  • BGL, blood glucose level; REM, rapid eye movement; SpO2, oxygen saturation; TCC, TeleClinical Care.